AVTR:NYE-Avantor Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 19.16

Change

0.00 (0.00)%

Market Cap

USD 13.05B

Volume

0.01B

Analyst Target

USD 23.81
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-09 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 66.00B
ALC Alcon AG

N/A

USD 44.97B
RMD ResMed Inc

N/A

USD 34.83B
BAX Baxter International Inc

N/A

USD 16.62B
ATR AptarGroup Inc

N/A

USD 10.46B
TFX Teleflex Incorporated

N/A

USD 8.43B
BLCO Bausch + Lomb Corp

N/A

USD 6.11B
STVN Stevanato Group SpA

N/A

USD 5.98B
WRBY Warby Parker Inc

N/A

USD 3.17B
INFU InfuSystems Holdings Inc

N/A

USD 0.17B

ETFs Containing AVTR

COPP Sprott Copper Miners ETF 10.10 % 0.00 %

N/A

N/A
CEBS:XETRA iShares Copper Miners UCI.. 5.18 % 0.00 %

N/A

USD 0.05B
COPG:LSE Global X Copper Miners UC.. 4.98 % 0.00 %

N/A

USD 0.15B
COPX Global X Copper Miners ET.. 4.94 % 0.65 %

N/A

USD 2.73B
WIRE:AU Global X Copper Miners ET.. 4.67 % 0.00 %

N/A

N/A
4COP:XETRA Global X Copper Miners UC.. 4.66 % 0.00 %

N/A

USD 0.09B
COPX:SW Global X Copper Miners UC.. 4.56 % 0.00 %

N/A

N/A
D6AT:XETRA Global X Disruptive Mater.. 4.46 % 0.00 %

N/A

N/A
COPX:LSE Global X Copper Miners UC.. 4.31 % 0.00 %

N/A

N/A
COPA Themes Copper Miners ETF 4.24 % 0.00 %

N/A

USD 0.47M
GMTL:AU Global X Green Metal Mine.. 4.04 % 0.00 %

N/A

N/A
EXV6:XETRA iShares STOXX Europe 600 .. 3.70 % 0.00 %

N/A

USD 0.37B
SETM:LSE 3.14 % 0.00 %

N/A

N/A
IJJ iShares S&P Mid-Cap 400 V.. 1.00 % 0.25 %

N/A

USD 8.59B
BSJO 0.00 % 0.42 %

N/A

N/A
IVOV Vanguard S&P Mid-Cap 400 .. 0.00 % 0.20 %

N/A

USD 0.95B
HYDW Xtrackers Low Beta High Y.. 0.00 % 0.25 %

N/A

USD 0.32B
PQIN 0.00 % 0.00 %

N/A

N/A
IESZ:LSE 0.00 % 0.00 %

N/A

N/A
EXV6:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
CRIT Optica Rare Earths & Crit.. 0.00 % 0.00 %

N/A

USD 3.36M
BRHY BlackRock High Yield ETF 0.00 % 0.00 %

N/A

USD 0.10B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.07% 16% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.07% 16% F 7% C-
Trailing 12 Months  
Capital Gain -17.45% 42% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.45% 42% F 11% F
Trailing 5 Years  
Capital Gain 10.11% 69% C- 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.11% 63% D 38% F
Average Annual (5 Year Horizon)  
Capital Gain 12.60% 79% B- 70% C-
Dividend Return 12.60% 79% B- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 46.92% 37% F 20% F
Risk Adjusted Return 26.85% 79% B- 41% F
Market Capitalization 13.05B 71% C- 88% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.